Who
David McIntyre
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Inhibikase Therapeutics; Chief Financial Officer, Avita Medical; CFO & COO, HeartWare International.
In numbers
- Trades disclosed
- 92
- Buys
- 2
- Sells
- 27
- Bought
- $16K
- Sold
- $6.1M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 2 Jul 2009
- Last trade
- 5 Jan 2026
- Last filed
- 7 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 7 Jan 2026 | IKT Inhibikase Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —986,319 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | IKT Inhibikase Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —986,319 at $0.00 | filing |
| 14 Apr 2025filed 16 Apr 2025 | IKT Inhibikase Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,775,539 at $0.00 | filing |
| 17 Jul 2020filed 21 Jul 2020 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Bought | $8,921393 at $22.70 | filing |
| 16 Jul 2020filed 21 Jul 2020 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Bought | $7,155300 at $23.85 | filing |
| 20 Dec 2011filed 21 Dec 2011 | HeartWare Internationaloption or derivative | SEC FORM 4 Code M | —3,125 at $0.00 | filing |
| 20 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Code M | —3,125 at $0.00 | filing |
| 20 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Sold | $184K2,701 at $68.09 | filing |
| 20 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Sold | $29K424 at $68.80 | filing |
| 19 Dec 2011filed 21 Dec 2011 | HeartWare Internationaloption or derivative | SEC FORM 4 Code M | —5,714 at $0.00 | filing |
| 19 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Sold | $112K1,623 at $69.12 | filing |
| 19 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Code M | $219K5,714 at $38.41 | filing |
| 19 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Sold | $280K4,114 at $68.08 | filing |
| 19 Dec 2011filed 21 Dec 2011 | HeartWare International | SEC FORM 4 Sold | $110K1,600 at $68.93 | filing |
| 19 Sep 2011filed 20 Sep 2011 | HeartWare International | SEC FORM 4 Sold | $69K1,251 at $55.02 | filing |
| 19 Sep 2011filed 20 Sep 2011 | HeartWare International | SEC FORM 4 Sold | $817K14,917 at $54.77 | filing |
| 16 Sep 2011filed 20 Sep 2011 | HeartWare Internationaloption or derivative | SEC FORM 4 Code M | —24,167 at $0.00 | filing |
| 16 Sep 2011filed 20 Sep 2011 | HeartWare International | SEC FORM 4 Code M | —24,167 at $0.00 | filing |
| 16 Sep 2011filed 20 Sep 2011 | HeartWare International | SEC FORM 4 Sold | $17K313 at $53.99 | filing |
| 16 Sep 2011filed 20 Sep 2011 | HeartWare International | SEC FORM 4 Sold | $63K1,149 at $55.03 | filing |
News
Ambu A/S (OTCMKTS:AMBBY) & Avita Medical (NASDAQ:RCEL) Head to Head AnalysisRCEL · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name David McIntyre; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.